Information Provided By: 
Fly News Breaks for February 7, 2017
ILMN, GNMK
Feb 7, 2017 | 08:36 EDT
Cowen analyst Doug Schenkel noted GenMark (GNMK) shares have declined 10% year-to-date, which he attributes to concerns surrounding Illumina's (ILMN) decision to discontinue NeoPrep. The analyst believes these concerns are overblown as the company has entered into an amended supply agreement, which was confirmed in their 10-Q. Schenkel maintained his Outperform rating and $17 price target on GenMark shares.
News For GNMK;ILMN From the Last 2 Days
There are no results for your query GNMK;ILMN
